Graphique du cours de l'action 02496.HK
YZYBIO-B (02496.HK)
Wuhan YZY Biopharma Co., Ltd.
HK$0
0%
$0
Marché fermé: May 07, 16:00:00 HKT
Retour
Wuhan YZY Biopharma Co., Ltd. (02496.HK)
Statistiques clés
Clôture préc.
--
Prix d'ouverture
--
Plage de la journée
-
Plage de 52 semaines
-
Volume
--
Volume moyen
--
Rendement en dividend
--
BPA (TTM)
--
Capitalisation boursière
--
Qu’est-ce que YZYBIO-B ?
Wuhan YZY Biopharma Co., Ltd. engages in the research, development, and industrialization of bispecific drugs. The company is headquartered in Wuhan, Hubei and currently employs 106 full-time employees. The company went IPO on 2023-09-25. The firm is committed to developing bispecific antibody (BsAb) based therapies for the treatment of cancer-related complications, cancer, and age-related eye diseases to address the medical needs in oncology and geriatric eye diseases. The firm's core product M701 is a recombinant BsAb that targets human cancer cell surface antigen EpCAM and human T cell surface antigen CD3. The firm's product pipeline also includes Y101D, Y332, Y225, and others.
Fonctionnalités
© 2026 Edgen fonctionné par
